Неадекватные операции при раке щитовидной железы (стр. 18 )

98.  Haugen, B. R. Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumors / B. R. Haugen, W. W. Woodmansee, M. T. McDermott // Clin. Endo. – 2002. – Vol. 56. – P. 281–290.

99.  Hegedus, L. Clinical practice. The thyroid nodule / L. Hegedus // N. Engl. J. Med. – 2004. – Vol. 351. – P. 1764–1771.

100. Increasing detection and increasing incidence in thyroid cancer / S. F. Hall, H. Walker, R. Siemens, A. Schneeberg // World rg.– 2009. Vol. 33. – P. 2567–2571.

101. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma / D. S. Tyler, D. J. Winchester, N. P. Caraway et al. // Surgery. – 1994. – Vol. 116. – P. 1054–1060.

102. Impact of initial surgical treatment on survival of patients with differentiated thyroid cancer: experience of an endocrine surgery center in an iodine-deficient region / M. Duren, N. Yavus, Y. Bukey et al. // World. rg. – 2000. – Vol. 24. – P. 1290–1294.

103. Large remnant (131)I ablation as an alternative to completion/total thyroidectomy in the treatment of well-differentiated thyroid cancer /G. Leblanc, R. Tabah, et al. // Surgery. – 2004. – Vol. 136. – Issue 6. – P. 1275–1280.

104. Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: acritical review of the risks and benefits of surgical intervention versus active surveillance / R. P. Tufano, G. Clayman, K. S. Heller et al.// Thyroid. - 2015. – Vol. 25, № 1. –P. 15–27.

105. Maxon, H. R. Detection of residual and recurrent thyroid cancer by radionuclide imaging / H. R. Maxon // Thyroid. – 1999. – Vol. 9. – P. 443–446.

106. Mazzaferri, E. L. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer / E. L. Mazzaferri, J. Hiang // Am. I. Med. – 1994. – Vol. 97. – P. 418–428.

107. McCaffrey, T. V. Invasive disease: management of the larynx / T. V. McCaffrey, G. W. Randolph // Surgery of the thyroid and parathyroid glands. – Philadelphia: Saunders, 2003. – P. 343 – 349.

108. Microcarcinoma of the thyroid: prevalence and morphology / I. Martirosyan, E. Troshina, P. Yuschkov et al. // Thyroid. – 2005. – Vol. 15. – Suppl. 1. – P. 140.

109. Moon, W. J. Are there any specific ultrasound findings of nodular hyperplasia (“leave me alone” lesion) to differentiate it from follicular adenoma? / W. J. Moon, H. J. Kwag, D. G. Na // Acta Radiologica – 2009. – Vol. 50. – P. 383–388.

110. Natural history, treatment, and course of papillary thyroid carcinoma / L. J. DeGroot, E. L. Kaplan, M. McCormic, F. H. Straus // J. Clin. Endocrinol. Metab. – 1990. – Vol. 71. – P. 414–424.

111. NCI Thyroid Fine Needle Aspiration State of Science Conference. – Diagn. Cytopathol. – 2008. – № 6. – P. 388–448.

112. New TNM classification for differentiated thyroid carcinoma (DTC): prognosis for tumor less or equal to 2 cm / T. Prot, L. Leenhardt, C. Hoang et al. // Thyroid. – 2005. – Vol. 15. – Suppl. 1 – P. 35.

113. Ohori, N. P. Variability in the Atypia of Undetermined Significance Follicular Lesion of Undetermined Significance Diagnosis in the Bethesda System for reporting Thyroid Cytopathology: Sources and Recommendations / N. P. Ohori, K. E. Schoedel // Acta Cytol. – 2011. – № 55. – P. 492–498.

114. Papillary microcarcinoma / S. Noguchi, H. Yamashita, S. Uchino, S. Watanabe // World rgery. – 2008. – Vol. 32. – P.747–753.

115. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long term outcome in 2444 consecutively treated patients / I. D. Hay, G. B. Thompson, C. S. Grant et al. // World rg. – 2002. – Vol. 26. – P. 879–885.

116. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period / I. D. Hay, M. E. Hutchinson, T. Gonzalez-Losada et al. // Surgery. – 2009. – Vol. 144. – P. 980–987.

117. Paz–Filho, G. Importance of thyroglobulin measurement at radioiodine thyroid remnant ablation simulated by recombinant TSH in patients with differentiated thyroid carcinoma / G. Paz-Filho, G. Carvalho, H. Graf // Thyroid. – 2005. – Vol. 15. – Suppl. 1. – P. 68.

118. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients / M. Volante, S. Landolfi, L. Chiusa et al. // Cancer. – 2004. – Vol. 100. – P. 950–957.

119. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer / M. Toubeau, C. Touzery, P. Arveux et al. // J. Nucl. Med. – 2004. – Vol. 45. – P. 988–994.

120. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules / G. Costante, D. Meringolo, C. Durante et al. // J. Clin. Endocr. Metab. – 2007. – Vol. 92. – P. 450–455.

121. Preston, D. Recent finding on cancer and noncancer risks in the atomic bombs survivors. Radiation Effects Research Foundation, Hiroshima, Japan / D. Preston // Хроническое радиационное воздействие: Возможности биологической индикации. – Челябинск, 2000. – С. 37.

122. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography / M. C. Frates, C. B. Benson, P. M. Doubilet et al. // J. Clin. Endocr. Metab. – 2006. – Vol. 91. – P. 3411–3417.

123. Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas / A. Rouxel, G. Hejblum, M. O. Bernier et al. // J. Clin. Endocrinol. Metab. – 2004. – Vol. 89. – P. 5362–5368.

124. Propuesta 2000 para el tratamiento del carcinoma diferentiado de tiroides / C. Belzarena, G. Lago, R. Lang et al. // Endocr. Nutr. – 2001. – Vol. 48. – № 3. – P. 708–77.

125. Randolph, G. rgery of the thyroid and parathyroid glands. – Philadelphia: Saunders, 2003. – 620 p.

126. Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma / A. Bachelot, A. F. Cailleux, M. Klain et al. // Thyroid. – 2002. – Vol. 12. – P.707–711.

127. Revised American Thyroid Association management guidlines for patients with thyroid nodules and differentiated thyroid cancer / D. S. Cooper, G. M. Doherty, R. H. Bryan et al. // Thyroid – 2009. – Vol.19, № 11. – P. 1167–1214.

128. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features / E. Papini, R. Guglielmi, A. Bianchini et al. // J. Clin. Endocrinol. Metab. – 2002. – Vol. 87. – P. 1941–1946.

129. Role of fine needle aspiration biopsy and frozen-section evaluationin the surgical management of thyroid nodules / P. Caraci, S. Aversa, A. Mussa et al. // Br. rg. – 2002. – № 89. – P. 797–801.

130. Role of fine–needle aspiration biopsy and frozen section examination in determining the extent of thyroidectomy / J. F. Hamming, M. R. Vriens, B. M. Goslings et al. // World rg. – 1998. – Vol. 22, № 6. – P. 575–580.

131. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration / K. Boelaert, J. Horacek, R. L. Holder et al. // J. Clin. Endocrinol. Metab. – 2006. – Vol. 91. – P. 4295–4301.

132. Shah, J. P. Cancer of the head and neck. Atlas of clinical oncology / J. P. Shah, G. P. Snahal – New-York: BC Decker Inc., 2001. – 484 p.

133. Shah, J. P. Хирургическое лечение местно-распространенного рака щитовидной железы /J. Shah // Рак щитовидной железы и эндемический зоб. Материалы межрегион. конф. с междунар. участием – Екатеринбург, 2007. – С. 24–25.

134.  Shah, J. P. Head and Neck Surgery and Oncology. Part 6. Management of Thyroid Neoplasms / J. P. Shah, S. G. Patel, B. Singh – Philadelphia: Elsevier; 2012. – 856 p.

135. Shaha, A. R. Differentiated thyroid cancer presenting initially with distant metastasis / A. R. Shaha, J. P. Shah, T. R. Loree // Am. rg. – 1997. – Vol. 174. – P. 474–476.

136. Shaha, A. R. Extended neck dissection / A. R. Shaha // rg. Oncol. – 1990. – Vol. 45, № 4. – P. 229–233.

137. Shaha, A. R. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid / A. R. Shaha, T. R. Loree, J. P. Shah // Surgery. – 1995. – Vol. 118. – P. 1131–1138.

138. Sherman, S. I. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group / S. I. Sherman, J. D. Brierley, M. Sperling et al. // Cancer. – 1998. – Vol. 83. – P. 1012–1021.

139. Sherman, S. I. Thyroid carcinoma / S. I. Sherman // Lancet. – 2003. – Vol. 361. – P. 501–511.

140. Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology / S. K. Shetty, M. M. Maher, P. F. Hahn et al. // Am. J. Roentgenol. – 2006. – Vol. 187, № 5. – P. 1349–1356.

141. Small papillary thyroid carcinoma: good biological behavior of intrathyroidal MPTC / L. Agate, D. Viola, M. Sculli et al. // Thyroid. – 2005. – Vol. 15. – Suppl. 1 – P. 36

142. Spectrum of Risk of Malignancy in Subcategories of `Atypia of Undetermined Significance` / M. T. Olson, D. P. Clark, Y. S. Erozan, S. Z. Ali // Acta Cytol. – 2011. – № 5. – P. 518–525.

143. Standardizing neck dissection terminology / K. T. Robbins, J. E. Medina, G. T. Wolfe et al. // Arch. Otolaryngol. Head Neck Surg. – 1991. – Vol. 117. – P. 601–605.

rgical reintervention for differentiated thyroid cancer / P. E. Goretzki, D. Simon, A. Frilling et al. // Br. rg. – 1993 – Vol.80, №8. – P.1009–1012.

spicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients // E. Robenshtok, S. Fish, A. Bach et al. // J. Clin. Endocrinol. Metab. - 2012. – Vol.97. – P.2706–2713

146. Tall cell variant: an aggressive form of papillary thyroid carcinoma / S. Prendiville, K. D. Burman, M. D. Ringel et al. // Otolaryngol. Head Neck Surg. – 2000. – Vol. 122. – P. 352–357.

147. The Bethesda Thyroid Fine Needle Aspiration Classification System: Year 1 at an Academic Institution / C. G.A. Theoharis, K. M. Schofield, L. Hammers et al. // Thyroid. – 2009. – № 19. – P. 1215–1226.

148. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies / F. Boi, G. Baghino, F. Atzeni et al. // J. Clin. Endocrinol. Metab. – 2006. – Vol. 91. – P. 1364–1369.

149. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules / R. Redman, H. Zalaznick, E. L. Mazzaferri, N. A. Massoll // Thyroid. – 2006. – Vol. 16. – P. 55–60.

150. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size / K. L. McCoy, N. Jabbour, J. B. Ogilvie et al. // Surgery. – 2007. – Vol. 142. – P. 837–844.

151. The predictive value of ultrasound findings in the management of thyroid nodules / C. Capelli, M. Castellano, I. Pirola et al. // Q. J.M. – 2007. – Vol. 100. – P. 29–35.

152. The role of fine needle aspiration and intraoperative frozen section in the surgical management of solitary thyroid nodules / S. D. Duek, D. Goldenberg, S. Linn et al. // Surg. Today. – 2002. – № 32. – P. 857–861.

153. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens / A. S. Kelman, A. Rathan, J. Leibowitz et al. // Thyroid. – 2001. – Vol. 11. – P. 271–277.

154. Thyroglobulin levels after rhTSH in thefollow-up of differentiated thyroid carcinoma / F. Carrilho, J. Gumaraes, T. Martins et al. // Thyroid. – 2005. – Vol. 15. – Suppl. 1. – P. 73.

155. Tuttle, R. M. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration / R. M. Tuttle, H. Lemar, H. B. Burch // Thyroid. – 1998. – Vol. 8. – P. 377–383.

156. Tuttle, R. M. The Chernobyl accident and its conseguences: Update at the millenium / R. M. Tuttle // Semin. Nukl. Med. – 2000. – Vol. 30, № 2. – P. 133–140.

157. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings / I. S. Nam-Goong, H. Y. Kim, G. Gong et al. // Clin. Endocrinol. (Oxf) – 2004. – Vol. 60. – P. 21–28.

158. Usefulness of ultrasonography in the management of nodular thyroid disease / E. Marqusee, C. B. Benson, M. C. Frates et al. // Ann. Int. Med. – 2000. – Vol. 133, № 9. – P. 696–700.

159. Value of repeated fine needle aspirations of the thyroid: an analysis of over ten thousand FNAs / Y. C. Oertel, L. Miyahara-Felipe, M. G. Mendoza, K. Yu // Thyroid. – 2007. – Vol. 17. – P. 1061–1066.

160. Van der Laan, P. A. Atypia of undetermined significance and nondiagnostic rates in the Bethesda system for reporting thyroid cytopathology are inversely related / P. A. Van der Laan, A. A. Renshaw, J. F. Krane – Am. J. Clin. Path. – 2012. – № 000. – P. 462–465.

161. Van der Laan, P. A. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? / P. A. Van der Laan, E. Marquesee, J. F. Krane // Am. J. Clin. Pathol. – 2011. – № 000. – P. 770–775.

162. When patients with differentiated thyroid cancers (DTC) are evaluated by sensitive thyroglobulin (Tg) assays, recombinant human TSH stimulation becomes unnecessary / C. Spencer, L. Bergogllio, M. Kazarosyan et al. // Thyroid. – 2005. – Vol. 15. – Suppl. 1. – P. 46.

163. Wilson, D. B. Thyroid reoperations: Indications and risks / D. B. Wilson, E. D. Staren, R. A. Prinz // rg. – 1998. – Vol. 64, № 7. – P. 674–679.

164. Xu, W. Value of reoperation after local resection of thyroid cancer / W. Xu, P. Tang, Z. Li // Chin. J. Oncolog. – 2002 – №2 – P. 240–245.

165. Ylagan, L. R. Fine-needle aspiration of the thyroid: a cytohistologic correlation and study of discrepant cases / L. R. Ylagan, T. Farkas, L. P. Dehner // Thyroid. – 2004. – Vol. 14. – P. 35–41.